Ryan C. Lynch, MD¹, Ryan D. Cassaday, MD², Stephen D. Smith, MD³, Jonathan R. Fromm, MD, PhD⁴, Andrew J. Cowan, M.D.^5,6, Edus H. Warren, MD, PhD^7,8, Mazyar Shadman, MD⁹, Andrei R Shustov, MD⁷, Brian G. Till, MD^8,10, Chaitra S. Ujjani, MD¹¹, Edward Libby, MD³, Mary Philip, MD, PhD¹², Hilary Coye, PA-C^13*, Christen N. Martino, NP^14*, Sandra Kanan, MSN, ARNP^13*, Karolyn K. Morris, BA^3*, Heather A. Rasmussen, BS^3*, Sanaz Behnia, MD^15*, Margaret E. Nartea, BS^8*, Jenna M. Voutsinas, MPH^5* and Ajay K. Gopal, MD^8,10

¹Seattle Cancer Care Alliance, University of Washington, Seattle, WA
²UW/FHCRC, Seattle, WA
³University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA
⁴Department of Laboratory Medicine, University of Washington, Seattle, WA
⁵Fred Hutchinson Cancer Research Center, Seattle, WA
⁶Division of Medical Oncology, University of Washington, Seattle, WA
⁷University of Washington, Seattle, WA
⁸Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
⁹Uw/Fred Hutchinson Cancer Research Center, Seattle, WA
¹⁰Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA
¹¹Seattle Cancer Care Alliance/Fred Hutchinson Cancer Research Center, Seattle, WA
¹²Department of Medicine/Division of Hematology&Oncology, Vanderbilt University Medical Center, Nashville, TN
¹³Seattle Cancer Care Alliance, Seattle, WA
¹⁴Seattle Cancer Care Alliance, Kenmore, WA
¹⁵Department of Radiology, University of Washington, Seattle, WA

Matthew J Ahearne^1*, Charlotte Gaskell, BSc, MSc^2*, Aimee E Jackson, BSc, MSc^2*, Clare Morland, PhD^3*, Louise Hopkins^3*, Nadia Nawaz^4*, Matthew A Timmins^1*, Christopher P Fox, MD, PhD^5*, Graham P. Collins, MD, DPhil⁶, Andrew Davies^7*, David John Lewis, MD^8*, Kate Cwynarski^9*, Kim Linton, MBChB, MRCP, PhD^10*, Pam McKay, MD^11*, Rod Johnson^12* and Simon D. Wagner¹

¹University Hospitals of Leicester NHS Trust, Leicester, United Kingdom
²Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom
³Cancer Research UK Clinical Trials Unit, Birmingham, United Kingdom
⁴University of Leicester, Leicester, United Kingdom
⁵Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
⁶Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⁷University of Southampton, Southampton, United Kingdom
⁸Plymouth Hospitals NHS Trust - Derriford Hospital, Plymouth, United Kingdom
⁹Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
¹⁰The Christie, Manchester, United Kingdom
¹¹Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
¹²St James’s Hospital Leeds, Leeds, United Kingdom

Gottfried von Keudell, MD, PhD¹, David Sermer, MD¹, Santosha Vardhana, MD, PhD^1*, Deanna Cho^1*, Erin Biggar, BA^1*, Alison J. Moskowitz, MD¹, Anita Kumar, MD^1,2, Connie Lee Batlevi, MD, PhD¹, Philip Caron, MD, PhD¹, Audrey Hamilton, MD^1*, Matthew J Matasar, MD, MS³, Steven M. Horwitz, MD¹, Heiko Schöder, MD^4*, Tira Bunyaviroch^5*, Andrew D. Zelenetz, MD, PhD⁶, Ahmet Dogan, MD, PhD⁷, Venkatraman Seshan, PhD^8*, Anas Younes, MD⁹ and Erel Joffe, MD, MSc¹

¹Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Medicine, Lymphoma Service, Memorial Sloan Kettering, Short Hills, NJ
³Department of Medicine, Lymphoma Service, Memorial Sloan-Kettering Cancer Center/New York Presbyterian, New York, NY
⁴Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Memorial Sloan Kettering Cancer Center, New York, NY
⁷Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
⁹AstraZeneca, New York, NY

Won-Seog Kim^1*, Dok-Hyun Yoon, MD, PhD^2*, Hyeon-Seok Eom^3*, Youngil Koh, MD, PhD⁴, Jae-Yong Kwak⁵, Won-Sik Lee⁶, Jong-Seok Lee^7*, Ho-Jin Shin^8*, Yuqin Song, MD, PhD^9*, Haiyan Yang, MD, PhD^10*, Mei Wang^11*, Jingrun Li, MD, PhD^11*, Xubin Huang^11*, Xueyuan Deng^11*, Kan Chen^11*, Zhenfan Yang^11* and Jun Zhu¹²

¹Department of Hematology and Oncology, Samsung Medical Center, Seoul, Korea, Republic of (South)
²Department of Oncology, Hematologic Cancer & BMT center, Asan Medical Center, Seoul, Korea, Republic of (South)
³Center for Hematologic Malignancy, National Cancer Center, Goyang, Korea, Republic of (South)
⁴Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea
⁵Department of Hematology and Oncology, Chonbuk National University Hospital, Jeonju, Korea, Republic of (South)
⁶Department of Hematology and Oncology, Inje University Busan Paik Hospital, Busan, Korea, Republic of (South)
⁷Division of Hematology & Medical Oncology, Seoul National University Bundang Hospital, Seoul, Korea, Republic of (South)
⁸Department of Internal Medicine, Pusan National University Hospital, Busan, Korea, Republic of (South)
⁹Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China
¹⁰Department of Lymphoma, Zhejiang Cancer Hospital, Hangzhou, China
¹¹Dizal Pharmaceuticals, Shanghai, China
¹²Department of Lymphoma, Beijing Cancer Hospital, Beijing, China

Luis E Malpica Castillo, MD¹, Denisse A. Castro, MD^2,3, Camila Peña, MD⁴, Henry Idrobo, MD^5,6*, Daniel J Enriquez, MD⁷, Lorena Fiad, MD^8*, Maria Prates, MD⁹, Victoria Otero, MD^10*, Mirna Churin, MD^11*, Milagros Altamirano, MD^12*, Kelly Meza, MD^13*, Celia Moises, MD^14*, Roberto Oviedo-Pecho, MD^14*, Antonio Paredes, MD^14*, Gadwyn Sanchez^14*, Laura Aguirre-Martinez, MS^15*, Bryan Valcarcel, MD^16*, Cristaldo Nancy, MD^17*, Juan L. Maradei, MD^18*, Luciana Guanchiale, MD^19*, Pablo Soto, MD^20*, Jose Luis Viñuela, MD^21*, Maria Elena Cabrera, MD^22*, Ursula Aviles-Perez^23*, Gustavo Sandival Ampuero, MD⁷, Sally Rose Paredes, MD^3,24*, Eloisa Riva, MD²⁵, Marcos Di Stefano, MD^26*, Andrea Noboa, MD^27*, Juan Antonio Choque, MD^28*, Myrna Candelaria, MD, PharmD²⁹, Alana Von Glasenapp, MD^30*, Fabiola Valvert, MD³¹, Marialejandra Torres Viera, MD^32*, Guilherme Fleury Perini, MD^33*, Eduardo Sotomayor, MD³⁴, Jorge J. Castillo, MD³⁵, Juan Carlos Ramos, MD, BS³⁶, Luis Villela Villela, MD, MC^37* and Brady Beltran, MD^38,39*

¹Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
²Centro de Investigación de Medicina de Precisión, Universidad de San Martin de Porres, Lima, Peru
³Departamento de Oncología y Radioterapia, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
⁴Hematology Department, Hospital Del Salvador, Santiago, Chile
⁵Facultad de Medicina., Universidad Del Valle, Cali, Colombia
⁶Hospital Universitario del Valle, Cali, Colombia
⁷Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru
⁸Hematología, Hospital Italiano de La Plata, La Plata, Argentina
⁹Hematology, Hospital Italiano La Plata, La Plata, Argentina
¹⁰Sección Hematología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
¹¹Grupo HTLV INBIRS (UBA-CONICET), Universidad de Buenos Aires, Buenos Aires, Argentina
¹²Medical Oncology Department, Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru
¹³Department of Pediatrics, Weill Cornell Medicine, New York, NY
¹⁴Servicio de Dermatologia, Departamento de Medicina, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
¹⁵Facultad de Salud, Universidad del Valle, Cali, Colombia
¹⁶Milken Institute School of Public Health, The George Washington University, Washington
¹⁷Hospital Italiano de Buenos Aires (HIBA), Buenos Aires, Argentina
¹⁸Servicio de Hematologia, Hospital Municipal Emilio Ferreyra, Necochea, Buenos Aires, Argentina
¹⁹Hospital Privado Universitario de Córdoba, Cordoba, Argentina
²⁰Hospital Dr. Eduardo Schütz Schroeder, Puerto Montt, Chile
²¹Servicio de Hematologia, Hospital Sótero de Rio, Santiago de Chile, Chile
²²Hematology Department, Hospital del Salvador, Santiago, Chile
²³Universidad Nacional Federico Villareal, Lima, Peru
²⁴Centro de Investigacion de Medicina de Precision, Universidad de San Martin de Porres, Lima, Peru
²⁵Cátedra de Hematología, Hospital de Clínicas, Facultad de Medicina, Montevideo, Uruguay
²⁶Hospital Solón Espinoza Ayala (SOLCA, Quito)/ Universidad San Francisco de Quito (USFQ), Quito, Ecuador
²⁷Servicio de Hematologia, Instituto Oncológico Nacional Dr. Juan Tanca Marengo, Guayaquil, Ecuador
²⁸Servicio de Hematologia, Caja Nacional de Salud - Hospital de Especialidades Materno Infantil La Paz, La Paz, Bolivia (Plurinational State of)
²⁹Research Division, Instituto Nacional de Cancerología, Mexico City, Mexico
³⁰Department of Hematology, Instituto de Prevision Social, Asuncion, Paraguay
³¹Instituto De Cancerología y Hospital Dr. Bernardo Del Valle (INCAN), Ciudad de Guatemala, Guatemala
³²Universidad Central de Venezuela, Caracas, Venezuela (Bolivarian Republic of)
³³Hospital Israelita Albert Einstein, Sao Paulo, PA, Brazil
³⁴George Washington University Cancer Center, Washington, DC
³⁵Bing Center for Waldenström Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA
³⁶Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
³⁷Internal Medicine division/Hematology and blood bank service, Centro Medico Dr. Ignacio Chavez/ISSSTESON/HermosilloSonora, Hermosillo, Mexico
³⁸Universidad de San Martin de Porres, Centro de Investigación de Medicina de Precisión, Lima, Peru
³⁹Departamento de Oncologia Medica y Radioterapia, Hospital Nacional Edgardo Rebagliati Martins, Lima, LIMA, Peru

Alex F. Herrera, MD¹, Hongli Li, MS^2*, Sharon M. Castellino, MD, MSc³, Sarah C. Rutherford, MD^4,5, Kelly Davison, MD^6*, Andrew G Evans, DO, MSc⁷, Angela Punnett, MD^8,9*, Louis S. Constine, MD¹⁰, David C. Hodgson, MD, MPH, FRCPC^11*, Susan K Parsons, MD, MRP¹², Anca Prica, MD¹³, Lale Kostakoglu, Prof, MD, PhD^14*, Margaret A. Shipp, MD¹⁵, Cara Laubach^16*, Michael L. Leblanc, PhD^2*, Michael Crump, MD¹⁷, Brad S. Kahl, MD¹⁸, John P. Leonard, MD¹⁹, Kara M. Kelly, MD²⁰, Sonali M. Smith, MD²¹ and Jonathan W. Friedberg, MD, MSSc²²

¹City of Hope, Duarte, CA
²SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA
³Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
⁴Meyer Cancer Center, Weill Cornell Medicine, New York, NY
⁵Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY
⁶McGill University, Montreal, QC, Canada
⁷University of Rochester Medical Center, Rochester, NY
⁸Hospital for Sick Children, Toronto
⁹Hospital for Sick Children, Toronto, ON, Canada
¹⁰Department of Radiation Oncology, Wilmot Cancer Institute, University of Rochester, Rochester, NY
¹¹Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
¹²Tufts Medical Center, Tufts University School of Medicine, Boston, MA
¹³Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
¹⁴Nuclear Medicine and Molecular Imaging, Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY
¹⁵Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
¹⁶SWOG, San Antonio, TX
¹⁷Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
¹⁸Washington University School of Medicine in St. Louis, Saint Louis, MO
¹⁹Weill Cornell Medical College, Pelham Manor, NY
²⁰Department of Pediatric Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY
²¹Department of Oncology, University of Chicago, Chicago, IL
²²Division of Hematology/Oncology, University of Rochester, Rochester, NY

Stefan K. Barta, MD, MRCP, MS¹, Tatyana A. Feldman, MD², Jennifer A. DeSimone, MD^3*, Ellen Kim^4*, Karthik Devajaran, PhD^5*, David Wiest, PhD⁶, Henry C.H. Fung, MD^7*, Richard I. Fisher, MD⁸, Carlyn Tan, MD⁹ and Nadia Khan, MD¹⁰

¹Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
²Hackensack University Medical Center, NY, NY
³Melanoma and Skin Oncology Center, INOVA, Fairfax, VA
⁴University of Pennsylvania School of Medicine, Philadelphia, PA
⁵The Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Phladelphia
⁶Fox Chase Cancer Center, Doylestown, PA
⁷Fox Chase Cancer Center, Phladelphia
⁸Department of Hematology/Oncology, Fox Chase Cancer Center,Temple University School of Medicine, Philadelphia, PA
⁹Fox Chase Cancer Center/Temple University, Philadelphia, PA
¹⁰Fox Chase Cancer Center, Philadelphia, PA

Ahmed Sawas, MD¹, Pei-Hsuan Chen^2*, Mikel Lipschitz, M.S.^3*, Scott Rodig, MD, PhD⁴ and George Vlad^5*

¹Herbert Irving Comprehensive Cancer Center, Department of Medicine, CUMC, New York, NY
²Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA
³Dana-Farber Cancer Institute, Boston, MA
⁴Department of Pathology, Brigham & Women's Hospital, Boston, MA
⁵Columbia University, Department of Pathology & Cell Biology, New York, NY

Alejandro Martin Garcia-Sancho, MD, PhD^1*, Socorro María Rodríguez-Pinilla, MD^2*, Eva Domingo-Domenech, MD^3*, Fina Climent, MD^4*, Joaquín Sánchez, MD^5*, Javier López Jiménez, MD, PhD^6*, Mónica García-Cosío, MD^7*, Josep Castellvi, MD^8*, Ana Julia González, MD^9*, Sonia González de Villambrosia, MD^10*, José Gómez Codina, MD^11*, Belén Navarro, MD^12*, Guillermo Rodríguez, MD^13*, Juan José Borrero, MD^14*, Máximo Fraga^15*, Andrea Naves^16*, Lourdes Baeza^17* and Raul Córdoba, MD, PhD¹⁸

¹Hematology Department, Hospital Clínico Universitario de Salamanca, IBSAL, Salamanca, Spain
²Pathology Department, Hospital Universitario Fundación Jiménez Díaz, CIBERONC, Madrid, Spain
³Hematology Department, Institut Catala D'oncologia, L'Hospitalet de Llobregat, Spain
⁴Pathology Department, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet De Llobregat, Spain
⁵Hematology Department and Pathology Department, Hospital Universitario Reina Sofía, Córdoba, Andalucía, Spain
⁶Hematology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
⁷Anatomical Pathology Department, Hospital Universitario Ramón y Cajal, CIBERONC, Madrid, Spain
⁸Department of Pathology, University Hospital Vall d'Hebron, Barcelona, Spain
⁹Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain
¹⁰Hematology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain
¹¹Medical Oncology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
¹²Hematology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain
¹³Hospital Universitario Virgen del Rocío, Seville, Spain
¹⁴Anatomical Pathology Department, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/Universidad de Sevilla, Sevilla, Spain
¹⁵Pathology Department, Hospital Clínico Universitario Santiago, Santiago de Compostela, Spain
¹⁶Medical Department, Takeda Farmacéutica España S.A., Madrid, Spain
¹⁷Medical Department, Takeda Farmacéutica España S.A, Madrid, Spain
¹⁸Department of Hematology, Fundacion Jimenez Diaz University Hospital, Madrid, Spain

David J. Straus, MD¹, Monika Dlugosz-Danecka, MD, PhD^2*, Joseph M. Connors, MD³, Árpád Illés, MD, PhD^4*, Marco Picardi, MD^5*, Ewa Lech-Marańda, MD, PhD^6*, Tatyana Feldman^7*, Piotr Smolewski, MD, PhD^8*, Kerry J. Savage, MD MSc⁹, Nancy L. Bartlett, MD^10*, Jan Walewski, MD^11*, Radhakrishnan Ramchandren, MD¹², Pier Luigi Zinzani, MD¹³, Martin Hutchings, MD, PhD^14*, Javier Munoz, MD¹⁵, Won Seog Kim, MD, PhD^16*, Ranjana Advani, MD¹⁷, Stephen M. Ansell, MD, PhD¹⁸, Anas Younes, MD¹⁹, Andrea Gallamini^20*, Rachael Liu, PhD^21*, Meredith Little, MPH^22*, Keenan Fenton^23*, Michelle A. Fanale, MD²⁴ and John A. Radford, MD, FMedSci^25*

¹Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
³BC Cancer, Vancouver, BC, Canada
⁴Faculty of Medicine, Department of Hematology, University of Debrecen, Debrecen, Hungary
⁵Federico II University, Naples, Italy
⁶Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
⁷Hackensack University Medical Center, Hackensack, NJ
⁸Medical University of Lodz, Lodz, Poland
⁹Centre for Lymphoid Cancer, Department of Medical Oncology, BC Cancer and University of British Columbia, Vancouver, BC, Canada
¹⁰Washington University School of Medicine Siteman Cancer Center, St. Louis, MO
¹¹Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
¹²The University of Tennessee Graduate School of Medicine, Knoxville, TN
¹³Bologna University, Bologna, Italy
¹⁴Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
¹⁵Banner MD Anderson Cancer Center, Gilbert, AZ
¹⁶Samsung Medical Center, Seoul, Korea, Republic of (South)
¹⁷Division of Oncology, Department of Medicine, Saul A. Rosenberg Professor of Lymphoma, Stanford Cancer Institute, Stanford, CA
¹⁸Division of Hematology, Mayo Clinic, Rochester, MN
¹⁹Memorial Sloan Kettering Cancer Center, New York City, NY
²⁰Antoine-Lacassagne Cancer Centre, Nice, France
²¹Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
²²Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceuticals Limited, Cambridge, MA
²³Seattle Genetics, Inc., Bothell, WA
²⁴Seattle Genetics, Bothell, WA
²⁵The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom

Philip A Haddad, MD and Neelakanta Dadi, MD

LSUHSC-S/Overton Brooks VAMC, Shreveport, LA

Sushanth Kakarla, MBBS¹, Gerardo Manuel Rosas, MD^2*, Sarah Allison Smith, MD^3*, Brian Warnecke, DO^2*, Joel E Michalek, PhD^4*, Qianqian Liu, PhD^5* and Adolfo Enrique Diaz Duque, MD, MSc⁶

¹Hematology, Mays Cancer Center UT Health San Antonio MD Anderson, San Antonio, TX
²University of Texas Health Science Center San Antonio, San Antonio, TX
³Internal Medicine, University of Texas Health Sciences Center San Antonio, San Antonio, TX
⁴The University of Texas Health Science Center At San Antonio, San Antonio, TX
⁵Department of Epidemiology and Biostatistics, University of Texas Health at San Antonio, San Antonio, TX
⁶Hematology-Oncology Division, Mays Cancer Center UT Health San Antonio MD Anderson, San Antonio, TX

Deepa Jagadeesh, MD, MPH¹, Robert B. Sims, MD² and Steven M. Horwitz, MD³

¹Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Solon, OH
²Seattle Genetics, Inc., Bothell, WA
³Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY

Neha Mehta-Shah, MD¹, Todd A Fehniger, MD, PhD², Eric D Jacobsen, MD³, Katrina Peterson^4*, Brad S. Kahl, MD⁵, Nancy L. Bartlett, MD^6*, Amanda F Cashen, MD⁷, Armin Ghobadi, MD^8*, Anne Fischer, BS^4*, Beth Reagan^4*, Alison J. Moskowitz, MD⁹, Fei Wan^4*, Ying Huang, PhD^10*, Kasey Hutt, PhD^10*, Edgar Vigil^11*, Meredith Olson^11*, Austin Jacobsen^10* and Steven M. Horwitz, MD⁹

¹Division of Medical Oncology, Washington University School of Medicine, St Louis, MO
²Department of Medicine, Washington University School of Medicine, Saint Louis, MO
³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Washington University in St. Louis, St. Louis, MO
⁵Washington University School of Medicine in St. Louis, Saint Louis, MO
⁶Department of Medicine, Washington University School of Medicine, St. Louis, MO
⁷Washington University School of Medicine, Saint Louis, MO
⁸Barnes Jewish Hospital, Washington University School of Medicine, St. Louis, MO
⁹Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁰Invivoscribe, Inc., San Diego, CA
¹¹Invivoscribe, Inc, San Diego, CA

Meredith I. Larose^1*, Steven M. Bair, MD², Shwetha Manjunath, MD^3*, Jordan Carter, MD^4*, Andrew M. Evens, DO, MMSc⁴, Krista Isaac, DO, MS⁵, Craig A. Portell, MD⁵, Sayan Chowdhury, PhD^6*, Narendranath Epperla, MD, MS⁶, Jordan Intrator^7*, Tatyana A. Feldman, MD⁷, Hayder Saeed, MD⁸, Leidy Isenalumhe, MD⁸, Daniel J. Landsburg, MD⁹, Sunita Dwivedy Nasta, MD⁹, James N. Gerson, MD⁹, Stefan K. Barta, MD, MRCP, MS⁹, Elise A. Chong, MD⁹, Stephen J. Schuster, MD⁹, Ima Paydar, MD^3*, John Plastaras, MD, PhD^3* and Jakub Svoboda, MD⁹

¹Department of Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
²Lymphoma Program, University of Colorado, Denver, CO
³Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
⁴Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
⁵Division of Hematology/Oncology, University of Virginia, Charlottesville, VA
⁶Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
⁷John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
⁸H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁹Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

Burhan Ferhanoglu, MD¹, Tae Min Kim, MD, PhD^2*, Amado Karduss, MD³, David Brittain, MBBCh, FC Path, Cert Clin Haem⁴, Gayane Tumyan^5*, Mubarak Al Mansour^6,7*, Marta Zerga, MD^8*, Yuqin Song, MD, PhD^9*, Silvia Rivas-Vera, MD¹⁰, Yok Lam Kwong, MD, FRCP^11,12*, Soon Thye Lim, MBBS, MRCP^13*, Su-Peng Yeh, MD^14*, Arif Abdillah, MD^15*, Zhongwen Huang^16*, Mehul Dalal, PhD^17*, Hui Wan, MD, PhD^15* and Mark Hertzberg, MBBS PhD FRACP FRCPA^18,19

¹Department of Internal Medicine, Division of Hematology, Koç University School of Medicine, Istanbul, Turkey
²Seoul National University Hospital, Seoul, South Korea
³Instituto de Cancerologia Las Americas, Medellin, Colombia
⁴Alberts Cellular Therapy, Pretoria, South Africa
⁵Department of Chemotherapy of Hemoblastosis, Blokhin Russian Cancer Research Center, Moscow, Russian Federation
⁶Princess Noorah Oncology Center, Jeddah, Saudi Arabia
⁷College of Medicine – Jeddah, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia
⁸Angel Roffo Institute, Buenos Aires, Argentina
⁹Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China
¹⁰Department of Hematology, Instituto Nacional de Cancerologia Mexico, Mexico City, Mexico
¹¹Hematology Division, Medical Oncology and Bone Marrow Transplantation, The University of Hong Kong, Hong Kong, Hong Kong
¹²Queen Mary Hospital, Hong Kong, Hong Kong
¹³Division of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore
¹⁴Medical University Hospital, Taichung, Taiwan
¹⁵Takeda Pharmaceuticals International Co., Singapore, Singapore
¹⁶Takeda R&D Data Science Institute, Takeda Pharmaceuticals International Co., Cambridge
¹⁷Global Outcomes Research, Takeda Pharmaceuticals International Co., Cambridge
¹⁸Department of Clinical Haematology, Prince of Wales Hospital, Sydney, Australia
¹⁹Faculty of Medicine, University of New South Wales, Sydney, Australia

Christopher J. Forlenza, MD^1*, Nitya Gulati, MBBS², Audrey Mauguen, PhD^3*, Michael J. Absalon⁴, Sharon M. Castellino, MD, MSc⁵, Anna Franklin, MD^6*, Frank G. Keller, M.D.⁷ and Neal Shukla, MD^8*

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX
³Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Cancer and Blood Diseases Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
⁵Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
⁶Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO
⁷Aflac Cancer and Blood Disorders Center, Emory University School of Medicine / Children's Healthcare of Atlanta, Atlanta, GA
⁸Department of Pediatrics, Memorial Sloan Kettering Cancer Center Pediatric Hematology/Oncology (PD), New York, NY

Joseph Boni^1*, Karin Havenith^2*, Mehdi Hamadani, MD³, Paolo F Caimi, MD⁴, Katie Anderson^2*, Tim Kopotsha^2*, Hans G Cruz⁵ and Jens Wuerthner^5*

¹Clinical Development, ADC Therapeutics America, Inc., Murray Hill, NJ
²Clinical Research, ADC Therapeutics (UK) Ltd, London, United Kingdom
³Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
⁴University Hospitals of Cleveland, Cleveland, OH
⁵Clinical Development, ADC Therapeutics SA, Epalinges, Switzerland

Sherif Louis, PhD, BSc, MSc^1*, Nathalie A Johnson, MD, PhD^2,3, Pierre Brousset, MD, PhD^4*, Olga Ludkovski, MSc^5*, Yulia Shifrin, PhD^5*, Sabine Mai, PhD^6* and Hans Knecht, MD⁷

¹Telo Genomics Corp., Winnipeg, MB, Canada
²Department of Medicine, McGill University, Montreal, QC, Canada
³Jewish General Hospital, Lady Davis Institute for Medical Research and Segal Cancer Centre, Montreal, QC, Canada
⁴Laboratoire D'Anatomie Pathologique, Toulouse, FRA
⁵Telo Genomics Corp., Toronto, ON, Canada
⁶Research Institute of Oncology and Hematology, CancerCare Manitoba, University of Manitoba, Winnipeg, MB, CAN
⁷Division of Hematology, Department of Medicine, Jewish General Hospital, Montréal, QC, CAN

Samer Al Hadidi, MD, MSc, FACP^1,2, Ranjit Nair, MD³, Raphael E Steiner, MD⁴, Sairah Ahmed, MD⁵, Paolo Strati, MD⁶, Simrit Parmar, M.D., MSCI⁷, Swami P. Iyer, MD⁸, Jillian R. Gunther, MD, PhD^9*, Chelsea C. Pinnix, MD, PhD^9*, Bouthaina S. Dabaja, MD^10*, Yago Nieto, MD¹¹, Felipe Samaniego, MD¹², Branko Cuglievan, MD^13*, Preetesh Jain, MBBS, MD, DM, PhD¹², Penny Fang, MD^10*, Roberto N. Miranda, MD^14*, Jeffrey Medeiros, MD^15*, Lei Feng, MS^16*, Hubert Chuang, MD PHD^17*, Michael Wang, MD¹² and Hun Ju Lee, MD¹²

¹Department of Hematology and Oncology, Baylor College of Medicine, Houston, TX
²Department of Lymphoma & Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, TX
³Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
⁵Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX
⁶Department of Lymphoma and Myeloma; Department of Translational Molecular Pathology, MD Anderson Cancer Center:, Houston, TX
⁷Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Lymphoma and Myeloma, University of Texas M.D. Anderson Cancer Center, Houston, TX
⁹Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Department of Stem Cell Transplantation and Cellular Therapy, UT M.D. Anderson Cancer Ctr., Houston, TX
¹²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹³Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁴Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
¹⁵Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁶University of Texas MD Anderson Cancer Center, Houston, TX
¹⁷U.T. M. D. Anderson Cancer Center, Houston, TX

Shafia Rahman, MD¹, Alvaro Alvarez Soto, MD^2*, Lindor Qunaj, MD^3*, Kenny Ye^4*, Kith Pradhan, PhD^5*, Astha Thakkar, MBBS^6,7, Zhu Cui, MD^5*, Michal Kasher Meron^8*, Angelica D'Aiello, MD^9*, Amanda Lombardo, PA-C, BS, MS^5*, Jennat Mustafa, PA-C^5*, Fariha Khatun, PA-C^5*, Kailyn Gillick, PA-C^5*, Felisha Joseph, PA-C^5*, Anjali Naik, PA-C^5*, Alyssa De Castro, PharmD^10*, Ulrich G. Steidl, MD/PhD¹¹, Hao Wang, MS^12*, Xiaoxin Ren^13*, Xingxing Zang, PhD^4*, Olga Derman, MD^14*, Kira Gritsman, MD, PhD⁴, Noah Kornblum, MD^1*, Aditi Shastri, MD¹, Ioannis Mantzaris, MD, MS¹, Mendel Goldfinger, MD^1*, Ira Braunschweig, MD^1*, B. Hilda Ye, PhD¹⁵, Amit Verma, MBBS¹, Murali Janakiram, MD¹⁶, Urvi A Shah, MD¹⁷ and R. Alejandro Sica, MD⁷

¹Hematology/Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
²Montefiore Medical Center Wakefield Campus, Bronx, NY
³Internal Medicine, Montefiore Medical Center/ Albert Einstein College of Medicine, Bronx, NY
⁴Albert Einstein College of Medicine, Bronx, NY
⁵Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
⁶Hematology and Oncology, Montefiore Medical Center, Bronx, NY
⁷Hematology/Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY
⁸Institute of Endocrinology, Sheba Medical Center, Tel-Hashomer, Israel, Ramat Gan, Israel
⁹Internal Medicine, Montefiore Medical Center, Bronx, NY
¹⁰Montefiore Medical Center, bronx, NY
¹¹Hematology/Oncology, Albert Einstein College of Medicine, Bronx, NY
¹²Albert Einstein College of Medicine, Bronx
¹³Montefiore Medical center, bronx
¹⁴Department of Hematology and Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
¹⁵Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY
¹⁶Division of Hematology, Oncology and Transplantation, University of Minnesota, Rochester, MN
¹⁷Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Ahmed Ludvigsen Al-Mashhadi^1*, Henrik Cederleuf, MD^2*, Jonas Hughes Larsen, J^1*, Torsten Holm Nielsen^3*, Martin Bjerregård Pedersen, MD, PhD^4*, Thomas Bech Mortensen^5*, Thomas Relander, MD, PhD^6*, Mats Jerkeman, MD, PhD⁷, Anne Ortved Gang, MD, PhD^8*, Anne Louise Kristensen^9*, Michael Roost Clausen, MD, PhD^10*, Marianne Tang Severinsen, MD, PhD^11*, Lasse H. Jakobsen, PhD^11*, Fredrik Ellin, MD, PhD^2* and Tarec Christoffer El-Galaly¹

¹Department of Haematology, Aalborg University Hospital, Aalborg, Denmark
²Department of Oncology, Skane University Hospital, Lund, Sweden
³Department of Haematology, Rigshospitalet, Copenhagen, Denmark
⁴Department of Haematology, Aarhus University Hospital, Aarhus, Denmark
⁵Department of Haematology, Odense University Hospital, Odense, Denmark
⁶Dept. of Oncology, Skane University Hospital, Lund, Sweden
⁷Department of Oncology, Lund University and Skane University Hospital, Lund, Sweden
⁸Dept. of Hematology, Herlev Hospital, Herlev, Denmark
⁹Department of Haematology, Zealand University Hospital, Roskilde, Denmark
¹⁰Department of Haematology, Vejle Hospital, Vejle, Denmark
¹¹Department of Hematology, Aalborg University Hospital, Aalborg, Denmark

Naveen Pemmaraju, MD¹, Vikas Gupta, MD, FRCP, FRCPath², Haris Ali, MD³, Abdulraheem Yacoub, MD⁴, Eunice S. Wang, MD⁵, Sangmin Lee, MD⁶, Gary J. Schiller, MD⁷, Christopher Brooks, PhD⁸, Nicole Rupprecht, MS^8*, Animesh Pardanani, MBBS, PhD⁹, Ayalew Tefferi, MD⁹, Moshe Talpaz, MD¹⁰, Minakshi S. Taparia, MBBS¹¹, Tariq I. Mughal, MD, FRCP^8,12*, Srdan Verstovsek, MD, PhD¹, Joseph D. Khoury, MD¹³ and Mrinal M. Patnaik, MD, MBBS⁹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Princess Margaret Cancer Centre, Toronto, ON, Canada
³City of Hope Medical Center, Duarte, CA
⁴University of Kansas Cancer Center, Westwood, KS
⁵Roswell Park Comprehensive Cancer Center, BUFFALO, NY
⁶Division of Hematology and Oncology, Weill Cornell Medicine and The New York-Presbyterian Hospital, New York, NY
⁷Ronald Reagan UCLA Medical Center, Los Angeles, CA
⁸Stemline Therapeutics, New York, NY
⁹Division of Hematology, Mayo Clinic, Rochester, MN
¹⁰University of Michigan Health Systems, Ann Arbor, MI
¹¹University of Alberta Hospital, Edmonton, AB, CAN
¹²Tufts Medical Center, Boston, MA
¹³The University of Texas MD Anderson Cancer Center, Houston, TX

Francesco Passamonti, MD^1*, Francesca Palandri, MD, PhD^2*, Guray Saydam, MD^3*, Miklos Egyed, MD, PhD^4*, Jeannie Callum, MD, FRCPC⁵, Timothy Devos, MD⁶, Serdar Sivgin, MD^7*, Paola Guglielmelli, MD⁸, Alessandro Vannucchi, MD⁹, Evren Zor, MD^10*, Geralyn Gilotti, MSc^11*, Yifan Zhang, PhD^11* and Martin Griesshammer, MD, PhD^12*

¹Division of Hematology, Department of Medicine and Surgery, University of Insubria, Varese, Italy
²Institute of Hematology "L. & A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy
³Division of Hematology, Department of Internal Medicine, School of Medicine, Ege University, Izmir, Turkey
⁴Hematology Department of Somogy County, Teaching Hospital Mór Kaposi, Kaposvár, Hungary
⁵Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Canada
⁶Department of Microbiology and Immunology, Laboratory of Molecular Immunology (Rega Institute), KU Leuven, Leuven, Belgium; Division of Hematology, University Hospitals Leuven, Leuven, Belgium
⁷Department of Hematology, Acibadem Kayseri Hospital, Kayseri, Turkey
⁸CRIMM; Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
⁹CRIMM; Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy
¹⁰Novartis Pharma AG, Basel, Switzerland
¹¹Novartis Pharmaceuticals Corporation, East Hanover, NJ
¹²University Clinic for Hematology, Oncology, Haemostaseology and Palliative Care, Johannes Wesling Medical Center, Minden, University of Bochum, Minden, Germany

Cem Akin, MD, PhD^1*, Hanneke Oude Elberink, MD, PhD^2*, Jason Gotlib, MD, MS³, Vito Sabato, MD, PhD^4*, Karin Hartmann, MD^5*, Sigurd Broesby-Olsen, MD^6*, Mariana Castells, MD, PhD^7*, Tsewang Tashi, MD^8*, Mark L. Heaney, MD⁹, Tracy I. George, MD¹⁰, Frank Siebenhaar, MD^11*, Deepti H. Radia, MRCPI, FRCPath^12*, Massimo Triggiani, MD, PhD^13*, Paul van Daele, MD^14*, Daniel J. DeAngelo, MD, PhD¹⁵, Iván Alvarez-Twose, MD, PhD^16*, Andreas Reiter, MD^17*, Peter Vadas, MD, PhD^18*, Patrizia Bonadonna, MD^19*, Paggy Hew, MS^20*, Hui-Min Lin, PhD^21*, Maria Roche, MS^20* and Marcus Maurer, MD^11*

¹University of Michigan, Ann Arbor, MI
²Department of Allergology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
³Division of Hematology, Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA
⁴Department of Immunology, Allergology and Rheumatology, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium
⁵University of Basel, Basel, Switzerland
⁶Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark
⁷Brigham and Women’s Hospital, Boston, MA
⁸Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁹Columbia University Medical Center, New York, NY
¹⁰ARUP Laboratories, University of Utah, Salt Lake City, UT
¹¹Corporate Member of Freie Universität Berlin, Humboldt - Universität zu Berlin, Dermatological Allergology, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany
¹²Department of Clinical Haematology, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom
¹³Division of Allergy and Clinical Immunology, University of Salerno, Salerno, Italy
¹⁴Department of Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands
¹⁵Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
¹⁶Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast), Virgen del Valle Hospital, Toledo, Spain
¹⁷University Hospital Mannheim, Heidelberg University, Mannheim, Germany
¹⁸Division of Allergy and Immunology, St. Michael's Hospital, Toronto, Canada
¹⁹USD di Allergologia, Azienda Ospedaliera Universitaria Integrata di Verona, Centro Ricerche Cliniche di Verona, Verona, Italy
²⁰Blueprint Medicines Corporation, Cambridge, MA
²¹Blueprint Medicines, Cambridge, MA

Roberto Latagliata^1*, Massimo Breccia, MD^2*, Ambra Di Veroli, MD^3*, Giulia Benevolo^4*, Elena M Elli, MD^5*, Francesco Cavazzini, MD^6*, Gianni Binotto, MD^7*, Alessia Tieghi, MD^8*, Mario Tiribelli, MD^9*, Florian H. Heidel, MD^10*, Massimiliano Bonifacio, MD^11*, Novella Pugliese, MD^12*, Giovanni Caocci, MD¹³, Monica Crugnola, MD^14*, Francesco Mendicino, MD^15*, Enrica Antonia Martino, MD^16*, Alessandra D'Addio, MD^17*, Simona Tomassetti, MD^18*, Bruno Martino, MD^19*, Daniela Bartoletti, MSc^20*, Giuseppe Auteri, MD^20*, Lucia Catani, PhD^20*, Rossella Stella, MD^9*, Fabio D'Amore, MD^7*, Luigi Scaffidi, MD^11*, Nicola Polverelli, MD^21*, Fabrizio Pane, MD²², Antonio Cuneo, MD^23*, Mauro Krampera, MD, PhD¹¹, Gianpietro Semenzato, MD^7*, Roberto Massimo Lemoli, MD^24*, Nicola Vianelli, MD^20*, Michele Cavo^20*, Giuseppe A. Palumbo, MD, PhD^25* and Francesca Palandri, MD, PhD^20*

¹Hematology Unit, Ospedale Belcolle, Viterbo, Italy
²Department of Translational and Precision Medicine, Sapienza University, Rome, Italy
³Hematology, Belcolle Hospital, Viterbo, Italy
⁴AOU Città della Salute e della Scienza di Torino, Turin, Italy
⁵Hematology, San Gerardo Hospital, MONZA, Italy
⁶Division of Hematology, Department of Medical Sciences, University of Ferrara, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna, Ferrara, Italy
⁷Department of Medicine, Hematology and Clinical Immunology, Padua School of Medicine, Padua, Italy
⁸Hematology Unit, Azienda Unità Sanitaria-IRCCS di Reggio Emilia, Reggio Emilia, Italy
⁹Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy
¹⁰Internal Medicine II, University Hospital Jena, Jena, Germany
¹¹Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
¹²Hematology Unit, University Federico II, Naples, Italy
¹³Department of Medical Sciences and Public Health, University of Cagliari, Businco Hospital, Cagliari, Italy
¹⁴Division of Hematology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
¹⁵Hematology Unit, Department of Hemato-Oncology, Ospedale Annunziata, Cosenza, Italy
¹⁶Division of Hematology, Azienda Policlinico-OVE, University of Catania, Catania, ITA
¹⁷Division of Hematology, Onco-hematologic Department, AUSL della Romagna, Ravenna, Ravenna, ITA
¹⁸Hematology Unit, Infermi Hospital Rimini, Rimini, ITA
¹⁹Haematology Dept.- Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italy
²⁰Institute of Hematology "L. & A. Seragnoli", Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy
²¹Bone Marrow Transplant Unit,, Institute of Hematology and Clinical Oncology “L. and A. SeràGnoli, Bologna, Italy
²²Federico II University of Naples, Hematology Department, Naples, Italy
²³Hematology, Azienda Ospedaliero Universitaria di Ferrara – University of Ferrara, Ferrara, ITA
²⁴Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino, Genova, Italy
²⁵Department of Medical, Surgical and Advanced Technology "G.F. Ingrassia", University of Catania, Catania, Italy

Aaron T. Gerds, MD, MS¹, Alessandro Vannucchi, MD², Francesco Passamonti^3*, Marina Kremyanskaya⁴, Jason Gotlib, MD MS^5*, Jeanne M. Palmer, Md⁶, Kelly McCaul^7*, Vincent Ribrag, MD⁸, Adam J. Mead, MD, PhD⁹, Claire Harrison, DM, FRCPath¹⁰, Ruben Mesa, MD¹¹, Jean-Jacques Kiladjian¹², Giovanni Barosi¹³, Torsten G. Gerike^14*, Jeevan K. Shetty^15*, Joseph Pariseau^14*, Gabriel Miranda^14*, Martin Schwickart^14*, Ana Carolina Giuseppi^14*, Jennie Zhang^14*, Jay T. Backstrom^16* and Srdan Verstovsek, MD, PhD¹⁷

¹Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
²Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, Florence, Italy
³Department of Medicine and Surgery, University of Insubria, Varese, Italy
⁴Division of Hematology/Medical Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY
⁵Stanford Cancer Institute, Stanford, CA
⁶Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ
⁷Avera Cancer Institute, Sioux Falls, SD
⁸Institut Gustave Roussy, Villejuif, France
⁹Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
¹⁰Guy's and Saint Thomas' NHS Foundation Trust, London, United Kingdom
¹¹Mays Cancer Center, UT Health San Antonio Cancer Center, San Antonio, TX
¹²Hôpital Saint-Louis et Université Paris Diderot, Paris, France
¹³IRCCS Policlinico San Matteo Foundation, Pavia, Italy
¹⁴Bristol Myers Squibb, Princeton, NJ
¹⁵Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland
¹⁶Acceleron Pharma, Cambridge, MA
¹⁷Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Caleb J. Smith, MD^1*, Gordon J. Ruan, MD^1*, John William Thomas^2*, Ayalew Tefferi, MD³, Ronald S. Go, MD³, Guarav Goyal^4* and Mithun Vinod Shah, MD, PhD³

¹Department of Internal Medicine, Mayo Clinic, Rochester, MN
²Department of Internal Medicine, University of Alabama at Birmingham, Birmingham, AL
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Division of Hematology, University of Alabama at Birmingham, Birmingham, AL

Francesca Palandri, MD, PhD^1*, Mario Tiribelli, MD^2*, Massimo Breccia, MD^3*, Daniela Bartoletti, MSc^1*, Elena M Elli, MD^4*, Giulia Benevolo^5*, Bruno Martino, MD^6*, Francesco Cavazzini, MD^7*, Alessia Tieghi, MD^8*, Alessandra Iurlo, MD, PhD^9*, Novella Pugliese, MD^10*, Monica Crugnola, MD^11*, Gianni Binotto, MD^12*, Giovanni Caocci, MD¹³, Giuseppe Auteri, MD^1*, Daniele Cattaneo, MD^14*, Lucia Catani, PhD^1*, Rossella Stella, MD^2*, Luigi Scaffidi, MD^15*, Nicola Polverelli, MD^16*, Giorgia Micucci, MD^17*, Elena Masselli, MD¹⁸, Costanza Bosi, MD^19*, Florian H. Heidel, MD^20*, Roberto Latagliata^21*, Fabrizio Pane, MD²², Antonio Cuneo, MD^23*, Mauro Krampera, MD, PhD¹⁵, Gianpietro Semenzato, MD^24*, Roberto M. Lemoli²⁵, Nicola Vianelli, MD^1*, Michele Cavo^1*, Giuseppe A. Palumbo, MD, PhD^26* and Massimiliano Bonifacio, MD^15*

¹Institute of Hematology "L. & A. Seragnoli", Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy
²Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy
³Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
⁴Hematology, San Gerardo Hospital, MONZA, Italy
⁵AOU Città della Salute e della Scienza di Torino, Turin, Italy
⁶Hematology Unit, A.O. Bianchi-Melacrino-Morelli, Reggio Calabria, Italy
⁷Division of Hematology, Department of Medical Sciences, University of Ferrara, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna, Ferrara, Italy
⁸Hematology Unit, Azienda Unità Sanitaria-IRCCS di Reggio Emilia, Reggio Emilia, Italy
⁹Hematology Division, Foundation IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milano, Italy
¹⁰Hematology - Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy
¹¹Hematology and BMT Center, Department of Medicine and Surgery, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
¹²Department of Medicine, Hematology and Clinical Immunology, Padua School of Medicine, Padua, Italy
¹³Hematology Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, ITA
¹⁴Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
¹⁵Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
¹⁶Unit of Blood Diseases and Stem Cell Transplantation, Dpt of Clinical and Experimental Sciences, University of Brescia, ASST-Spedali Civili di Brescia, Brescia, Italy
¹⁷Hematology and Stem Cell Transplant Center, AORMN Hospital, Pesaro, Italy
¹⁸Haematology and BMT Centre, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
¹⁹Division of Hematology, AUSL di Piacenza, Piacenza, Piacenza, Italy
²⁰Internal Medicine II, Hematology and Oncology, Friedrich-Schiller-University Medical Center, Jena, Germany, Jena, Germany
²¹Hematology Unit, Ospedale Belcolle, Viterbo, Italy
²²Federico II University of Naples, Hematology Department, Naples, Italy
²³Division of Hematology, University of Ferrara, Ferrara, Ferrara, Italy
²⁴Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy
²⁵Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS AOU San Martino-IST, Genova, Genova, Italy
²⁶Dipartimento di Scienze Mediche Chirurgiche e Tecnologie Avanzate "G.F. Ingrassia", Università degli Studi di Catania, Catania, Italy

Lucia Masarova, MD^1*, Prithviraj Bose, MD², Naveen Pemmaraju, MD¹, Lingsha Zhou^1*, Sherry A. Pierce, BSN, BA^1*, Zeev E. Estrov, MD¹, Hagop M. Kantarjian, MD³ and Srdan Verstovsek, MD, PhD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, Professor and Chairman, Department of Leukemia, Samsung Distinguished University Chair in Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Richa Parikh, MD^1*, Ronald S. Go, MD² and Gaurav Goyal, MD³

¹Myeloma Center, Division of Hematology/Oncology, University of Arkansas for Medical Sciences, Little Rock, AR
²Mayo Clinic Rochester, Division of Hematology, Onalaska, WI
³University of Alabama at Birmingham, Birmingham, AL

Andrew Charles Perkins, MBBS, PhD¹, Kate Burbury, MBBS, FRACP, FRCPA, DPhil^2*, Thomas Lehmann, MD^3*, David M Ross, MBBS, PhD, FRACP, FRCPA^4*, Andreas Reiter, MD^5*, Vikas Gupta, MD, FRCP, FRCPath⁶, Claire Harrison, DM, FRCPath⁷, Jean-Jacques Kiladjian, MD, PhD^8*, Alessandro Vannucchi, MD⁹, Marielle Wondergem, MD¹⁰, Robert Pack, PhD^11*, Monika Wroclawska, MD^11*, Celine Wilke, MD^11*, Angela Zhang, PhD^11* and Florian H. Heidel, MD^12*

¹Australian Centre for Blood Diseases, Monash University, Malvern, VIC, Australia
²Peter MacCallum Cancer Centre, Melbourne, Australia
³Kantonsspital St. Gallen, St. Gallen, CHE
⁴Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, SA, Australia
⁵Department of Hematology and Oncology, Universitätsklinikum Mannheim, Mannheim, Germany
⁶Princess Margaret Cancer Centre, Toronto, ON, Canada
⁷Guy's and Saint Thomas' NHS Foundation Trust, London, United Kingdom
⁸Université de Paris, Clinical Investigations Center, Saint-Louis hospital, APHP, Paris, FRA
⁹Center Research and Innovation of Myeloproliferative Neoplasms - CRIMM, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
¹⁰VU University Medical Center, Amsterdam, NLD
¹¹Novartis Pharma AG, Basel, Switzerland
¹²Universitätsklinikum Jena, Jena, Germany

Srdan Verstovsek, MD, PhD¹, Ariel Han, MMSc^2*, Karin Chun Hayes^3*, Tracy Woody, BS^4*, Frank Valone, MD^5* and Suneel K Gupta, PhD^6*

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²PRA International, Symphony Health, Blue bell, PA
³PRA International, Symphony Health Solutions, Phoenix, AZ
⁴Protagonist Therapeutics, Newark, CA
⁵Protagonist Therapeutics, Mill Valley, CA
⁶Protagonist Therapeutics, Sunnyvale, CA

Anand Ashwin Patel, MD¹, Kirk Cahill, MD^1*, Angella Charnot-Katsikas, MD^2*, Hongtao Liu, MD, PhD¹, Sandeep Gurbuxani, MBBS, PhD², Michael Thirman, MD¹, Satyajit Kosuri, MD^3*, Richard A. Larson, MD³, Wendy Stock, MD¹, Jeremy Segal^4* and Olatoyosi Odenike, MD¹

¹Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL
²Department of Pathology, University of Chicago, Chicago, IL
³Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
⁴Department of Pathology, The University of Chicago, Chicago, IL

Robyn Marie Scherber, MD, MPH^1*, Lindsey Whyte^2*, Denise Pearl^3*, John Mascarenhas, MD⁴, Srdan Verstovsek, MD, PhD⁵, Claire Harrison, DM, FRCPath⁶, Amylou C. Dueck, PhD⁷, Michelle Woehrle^2*, Rick Winneker, PhD², Ruben Mesa, MD⁸ and Alison R. Moliterno, MD⁹

¹Mays Cancer Center at UT Health San Antonio and MD Anderson Cancer Center, San Antonio, TX
²MPN Research Foundation, Chicago, IL
³MPN Research Foundation, Chicago
⁴Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
⁵Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Clinical Haematology, Guys and St Thomas NHS Trust, London, United Kingdom
⁷Health Sciences Research, Mayo Clinic, Scottsdale, AZ
⁸Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX
⁹Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

Jalaja Potluri, MD¹, Jason Harb, PhD^2*, Abdullah A. Masud, PhD^1* and Jessica E. Hutti, PhD^1*

¹AbbVie Inc., North Chicago, IL
²AbbVie, Inc., North Chicago, IL

Tracy I. George, MD¹, Gerard Hoehn, PhD^2*, Hui-Min Lin, PhD^2*, Stephen Miller, PhD^2* and Cem Akin, MD, PhD^3*

¹University of Utah and ARUP Laboratories, Salt Lake City, UT
²Blueprint Medicines Corporation, Cambridge, MA
³University of Michigan, Ann Arbor, MI

Nicolas Gauthier, MD^1*, Juliette Soret-Dulphy, MD^1*, Lin-Pierre Zhao, MD^1*, Rafael Daltro De Oliveira, MD^1*, Clemence Marcault^2*, Nathalie Parquet, MD^3*, Jean-Marc Zini^3*, Delphine Rea, MD, PhD³, Emmanuel Raffoux, MD^4*, Bruno Cassinat, PharmD, PhD^5,6*, Stephane Giraudier, MD, PhD^6,7*, Jean-Jacques Kiladjian^8,9 and Lina Benajiba, MD, PhD^10*

¹Université de Paris, Clinical Investigations Center, Saint-Louis hospital, APHP, Paris, France
²Saint-Louis, Nice, France
³Université de Paris, Hematology department, Saint-Louis hospital, APHP, Paris, France
⁴Hématologie clinique, Hôpital Saint-Louis, Paris, France
⁵Institut de Recherche St Louis, Université de Paris, INSERM U1131, Paris, France
⁶Université de Paris, Cellular biology Department, Saint-Louis hospital, APHP, Paris, France
⁷UMRS_1131, Inserm, Université de Paris, Institut de recherche Saint-Louis, Paris, France
⁸INSERM UMR 944, Saint-Louis Research Institute, Paris, France
⁹Centre d'Investigations Cliniques (INSERM CIC 1427), AP-HP, Hôpital Saint-Louis, Université de Paris, Paris, France
¹⁰APHP, INSERM U944, Institute of Hematology - St Louis Hospital, PARIS, France

Animesh Pardanani, MBBS, PhD¹, Richard M. Stone, MD², Moshe Talpaz, MD^3*, Jorge E. Cortes, MD⁴, Catriona Jamieson, MD, PhD⁵, Shelonitda Rose, MD^6*, Jun Zhang, PhD^6* and Ayalew Tefferi, MD¹

¹Mayo Clinic of Rochester, Rochester, MN
²Dana-Farber Cancer Institute, Boston, MA
³University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
⁴Georgia Cancer Center, Augusta, GA
⁵Moores Cancer Center, University of California, San Diego, La Jolla, CA
⁶Bristol Myers Squibb, Princeton, NJ